Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Wu-Chou Su
2016

Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility

Yang, S. Y., Hsiung, C. N., Li, Y. J., Chang, G. C., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Yang, P. C., Chen, C. J., Wu, P. E., Yu, J. C., Shen, C. Y. & Hsu, H. M., 2016 Feb 3, In : Journal of biomedical science. 23, 1, 23.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Positive feedback regulation between IL10 and EGFR promotes lung cancer formation

Hsu, T. I., Wang, Y-C., Hung, C. Y., Yu, C. H., Su, W-C., Chang, W. C. & Hung, J-J., 2016 Apr 12, In : Oncotarget. 7, 15, p. 20840-20854 15 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2017

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))

Jen, J., Lin, L. L., Lo, F. Y., Chen, H. T., Liao, S. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2017 Aug 1, In : Oncogene. 36, 31, 1 p.

Research output: Contribution to journalComment/debate

Open Access
2016

Epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene fusion: Detection in malignant pleural effusion by RNA or PNA analysis

Chen, Y. L., Lee, C. T., Lu, C. C., Yang, S. C., Chen, W. L., Lee, Y. C., Yang, C. H., Peng, S. L., Su, W. C., Chow, N. H. & Ho, C. L., 2016 Jun, In : PloS one. 11, 6, e0158125.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2020
Open Access
2017
22 Citations (Scopus)
2020

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

Bang, Y. J., Su, W. C., Schuler, M., Nam, D. H., Lim, W. T., Bauer, T. M., Azaro, A., Poon, R. T. P., Hong, D., Lin, C. C., Akimov, M., Ghebremariam, S., Zhao, S., Giovannini, M. & Ma, B., 2020 Feb 1, In : Cancer Science. 111, 2, p. 536-547 12 p.

Research output: Contribution to journalArticle

Open Access
3 Citations (Scopus)

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Nishio, M., Felip, E., Orlov, S., Park, K., Yu, C. J., Tsai, C. M., Cobo, M., McKeage, M., Su, W. C., Mok, T., Scagliotti, G. V., Spigel, D. R., Viraswami-Appanna, K., Chen, Z., Passos, V. Q. & Shaw, A. T., 2020 Apr, In : Journal of Thoracic Oncology. 15, 4, p. 609-617 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2019

Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. & 2 others, Rukazenkov, Y. & Ramalingam, S. S., 2019 Nov 15, In : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2020

Electric Field–Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva

Tu, M., Cheng, J., Chen, Y. L., Jea, W. C., Chen, W. L., Chen, C. J., Ho, C. L., Huang, W. L., Lin, C. C., Su, W. C., Ye, Q., Deignan, J., Grody, W., Li, F., Chia, D., Wei, F., Liao, W., Wong, D. T. W. & Strom, C. M., 2020 Aug, In : Journal of Molecular Diagnostics. 22, 8, p. 1050-1062 13 p.

Research output: Contribution to journalArticle

2019

Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison

Chen, Y., Lin, C., Yang, S., Chen, W., Chen, J., Hou, Y., Lu, C., Chow, N., Su, W. & Ho, C., 2019 Jul 16, In : Frontiers in Oncology. 9, p. 631

Research output: Contribution to journalArticle

2018

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

ATLANTIC Investigators, 2018 Apr, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

145 Citations (Scopus)
2017

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 Nov, In : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

Research output: Contribution to journalArticle

34 Citations (Scopus)
2019

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 Jul 16, In : British Journal of Cancer. 121, 2, p. 131-138 8 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
2020

Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women

Chen, T. Y., Fang, Y. H., Chen, H. L., Chang, C. H., Huang, H., Chen, Y. S., Liao, K. M., Wu, H. Y., Chang, G. C., Tsai, Y. H., Wang, C. L., Chen, Y. M., Huang, M. S., Su, W. C., Yang, P. C., Chen, C. J., Hsiao, C. F. & Hsiung, C. A., 2020 Dec 1, In : Scientific reports. 10, 1, 6774.

Research output: Contribution to journalArticle

Open Access
2017

Wheat germ agglutinin-induced paraptosis-like cell death and protective autophagy is mediated by autophagy-linked FYVE inhibition

Tsai, T. L., Wang, H. C., Hung, C. H., Lin, P. C., Lee, Y. S., Chen, H. H. W. & Su, W. C., 2017 Jan 1, In : Oncotarget. 8, 53, p. 91209-91222 14 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2016
7 Citations (Scopus)
2017

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W. P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S. B., Chiu, W. T., Hung, J. J., Liu, T. L., Wu, W. S., Wu, P. Y., Su, W. C., Chang, J. Y. & Liaw, H., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2016

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W. C., Albiges, L., Lin, C. C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N. & Culine, S., 2016 Mar 1, In : Annals of Oncology. 27, 3, p. 449-454 6 p., mdv609.

Research output: Contribution to journalArticle

30 Citations (Scopus)

Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs

Hwu, J. R., Tsay, S. C., Chuang, K. S., Kapoor, M., Lin, J. Y., Yeh, C. S., Su, W. C., Wu, P. C., Tsai, T. L., Wang, P. W. & Shieh, D. B., 2016 Feb 5, In : Chemistry - A European Journal. 22, 6, p. 1926-1930 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2017

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

Lu, C. S., Shieh, G. S., Wang, C. T., Su, B. H., Su, Y. C., Chen, Y. C., Su, W. C., Wu, P., Yang, W. H., Shiau, A. L. & Wu, C. L., 2017, In : Oncotarget. 8, 19, p. 30844-30858 15 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors

Chang, I. S., Jiang, S. S., Yang, J. C. H., Su, W. C., Chien, L. H., Hsiao, C. F., Lee, J. H., Chen, C. Y., Chen, C. H., Chang, G. C., Wang, Z., Lo, F. Y., Chen, K. Y., Wang, W. C., Chen, Y. M., Huang, M. S., Tsai, Y. H., Su, Y. C., Hsieh, W. S., Shih, W. C. & 8 others, Shieh, S. H., Yang, T. Y., Lan, Q., Rothman, N., Chen, C. J., Chanock, S. J., Yang, P. C. & Hsiung, C. A., 2017 Mar 1, In : American Journal of Respiratory and Critical Care Medicine. 195, 5, p. 663-673 11 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis

Tzeng, H. T., Tsai, C. H., Yen, Y. T., Cheng, H. C., Chen, Y. C., Pu, S. W., Wang, Y. S., Shan, Y. S., Tseng, Y. L., Su, W. C., Lai, W. W., Wu, L. W. & Wang, Y. C., 2017 May 1, In : Clinical Cancer Research. 23, 9, p. 2335-2345 11 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. & 166 others, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017, In : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017 Jan 1, In : Annals of Oncology. 28, 3, p. 528-534 7 p.

Research output: Contribution to journalArticle

57 Citations (Scopus)
11 Citations (Scopus)
2019
Open Access
1 Citation (Scopus)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. & 96 others, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., 2019 Dec, In : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)
2020

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study

Herbst, R. S., Garon, E. B., Kim, D. W., Cho, B. C., Perez-Gracia, J. L., Han, J. Y., Arvis, C. D., Majem, M., Forster, M. D., Monnet, I., Novello, S., Szalai, Z., Gubens, M. A., Su, W. C., Ceresoli, G. L., Samkari, A., Jensen, E. H., Lubiniecki, G. M. & Baas, P., 2020 May 10, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 14, p. 1580-1590 11 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

Wong, J. Y. Y., Zhang, H., Hsiung, C. A., Shiraishi, K., Yu, K., Matsuo, K., Wong, M. P., Hong, Y. C., Wang, J., Seow, W. J., Wang, Z., Song, M., Kim, H. N., Chang, I. S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J. H. & 166 others, Seow, A., Caporaso, N. E., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Yang, Y., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Cai, Q., Yin, Z., Kim, Y. C., Bassig, B. A., Chang, J., Ho, J. C. M., Ji, B. T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H. D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Shi, J., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Chien, L. H., Xiang, Y. B., Park, J. Y., Kweon, S. S., Chen, C. J., Lee, K. M., Blechter, B., Li, H., Gao, Y. T., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S. I., Wu, W., Pang, H., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Zhu, M., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Hsin, M., Sit, K. Y., Ho, J., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Lin, C. C., Park, I. K., Xu, P., Wang, Y., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Chen, T. Y., Jiang, S. S., Liu, J., Yamaji, T., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Yang, K., Jiang, G., Fei, K., Wu, G., Lin, H. C., Chen, H. L., Fang, Y. H., Tsai, F. Y., Hsieh, W. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Rieswijk, L., Chao, A., Yang, P. C., Shu, X. O., Wu, T., Wu, Y. L., Lin, D., Chen, K., Zhou, B., Huang, Y. C., Kohno, T., Shen, H., Chanock, S. J., Rothman, N. & Lan, Q., 2020 Mar, In : Genomics. 112, 2, p. 1223-1232 10 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2019

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, T. S. K., Wu, Y. L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., Kubota, K., Lubiniecki, G. M., Zhang, J., Kush, D., Lopes, G., Gomez Aubin, G., Fein, L., Kaen, D., Kowalyszyn, R., Lerzo, G. & 236 others, Martinengo, G., Molina, M., Richardet, E., Picon, P., Varela, M., Zarba, J. J., de Azevedo, S. J., Barrios, C. H., Beato, C., Cerny, C. A. S., De Marchi, P. R. M., Fernandes, G., Franke, F. A., Freitas, H., Girotto, G., Lopes, V., Santos, L., Costa, M. A., Shimada, A. K., Smaletz, O., Soares, J. P. H., Victorino, A. P., Ferreira, C., Koleva, M., Koynov, K., Micheva, R., Deliverski, T., Milanova, Z., Doganov, B., Cheng, S., De Angelis, F., Speranza, G., Juergens, R. A., Ksienski, D., Fenton, D., Aren, O., Caglevic, C., Galindo, H., Rey, F., Chang, J., Chen, G., Chen, X., Ouyang, X., Cheng, Y., Ding, Z., Hou, M., Fan, Y., Feng, J., He, J., He, Y., Hu, Y., Li, W., Liu, X., Liu, Z., Lu, S., Qin, S., Tang, Q., Wang, B., Wang, K., Zhang, L., Zhang, X., Zhao, J., Wang, J., Zhou, C., Zhou, J., Zhou, Q., Wu, Y., Cardona, A., Duarte, R., Gomez Wolff, L., Zambrano, A., Vallejo, M., Havel, L., Kolek, V., Kolman, P., Koubkova, L., Petruzelka, L., Popelkova, P., Roubec, J., Vanasek, J., Vlasek, T., Jaal, J., Kuusk, G., Avendano, O., Castro, H., Lopez, K., Sandoval, M., Ho, C. M. J., Lo, S. H., Laczo, I., Piko, B., Ostoros, G., Aoe, K., Fujisaka, Y., Hirashima, T., Horiike, A., Hosomi, Y., Hotta, K., Ichiki, M., Imamura, F., Iwamoto, Y., Kasahara, K., Katakami, N., Kato, T., Murakami, S., Kawaguchi, T., Kishi, K., Kubota, K., Kurata, T., Torii, Y., Nakahara, Y., Nishimura, T., Ohira, T., Saka, H., Sawa, T., Seki, N., Sugawara, S., Takahashi, K., Takigawa, N., Tanaka, H., Yamada, K., Yokoyama, T., Yokoyama, T., Yoshioka, H., Kudaba, I., Purkalne, G., Stara, Z., Cesas, A., Cicenas, S., Zemaitis, M., How, S. H., Liam, C. K., Ong, C. K., Tho, L. M., Arrieta Rodriguez, O., de The Bustamante Valles, F., Hernandez Hernandez, C., Mas, L., Vera, L., Salas, J., Tejada, H., Edusma-Dy, R., Galvez, C., Ladrera, G. E. I., Tan Chun Bing, J., Jassem, J., Kalinka-Warzocha, E., Karaszewska, B., Kazarnowicz, A., Kowalski, D., Lesniewski Kmak, K., Ramlau, R., Araujo, A., Barata, F., Gil, N., Hespanhol, V., Alexandru, A., Dediu, M., Cherciu, N., Ciurescu, D., Ganea, D., Miron, L., Sirbu, D., Turdean, M., Emelyanov, S., Karaseva, N., Kuzina, L., Lazarev, S., Lifirenko, I., Bolotina, L., Lipatov, O., Ovchinnikova, E., Matrosova, M., Alyasova, A., Poltoratsky, A., Taranov, P., Zarubenkov, O., Cohen, G., Dreosti, L., Seolwane, F., Hall, J., Hart, G., Jordaan, C., Buddu, S., Botha, M., Landers, G., Rappaport, B., Ruff, P., Shepherd, L., Szpak, W., Ahn, M. J., Cho, B. C., Kim, J. H., Bergstrom, P., Ohman, R., Griph, H., Betticher, D., Ochsenbein, A., Zippelius, A., Chan, G. C., Chiu, C. H., Hsia, T. C., Su, W. C., Yang, C. H., Ativitavas, T., Danchaivijitr, P., Srimuninnimit, V., Seetalarom, K., Sookprasert, A., Sriuranpong, V., Altundag, O., Cay Senler, F., Erman, M., Goksel, T., Goker, E., Ozyilkan, O., Seker, M., Gumus, M., Turna, H., Yumuk, F., Adamchuk, G., Bondarenko, I., Ivashchuk, O., Ponomarova, O., Rusyn, A., Shevnya, S., Shparyk, Y., Sinielnikov, I., Andrusenko, O., Trukhyn, D., Ursol, G., Vynnychenko, I., Nguyen, T. Q., Pham, X. D., Castro, G. & Kubota, K., 2019 May 4, In : The Lancet. 393, 10183, p. 1819-1830 12 p.

Research output: Contribution to journalArticle

257 Citations (Scopus)
2017

Liquid biopsy genotyping in lung cancer: Ready for clinical utility?

Huang, W. L., Chen, Y. L., Yang, S. C., Ho, C. L., Wei, F., Wong, D. T., Su, W. C. & Lin, C. C., 2017 Jan 1, In : Oncotarget. 8, 11, p. 18590-18608 19 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)
2018

Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer

Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., Okamoto, I., Zhou, C., Cho, B. C., Cheng, Y., Cho, E. K., Voon, P. J., Planchard, D., Su, W. C., Gray, J. E., Lee, S. M. & 4 others, Hodge, R., Marotti, M., Rukazenkov, Y. & Ramalingam, S. S., 2018 Jan 11, In : New England Journal of Medicine. 378, 2, p. 113-125 13 p.

Research output: Contribution to journalArticle

918 Citations (Scopus)
9 Citations (Scopus)
2019

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Lin, C. Y., Hwang, J. S., Wang, W. C., Lai, W. W., Su, W. C., Wu, T. Y., Yao, G. & Wang, J. D., 2019 Jan, In : Journal of the Formosan Medical Association. 118, 1P2, p. 215-222 8 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)
2018

Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Wei, F., Strom, C. M., Cheng, J., Lin, C. C., Hsu, C. Y., Soo Hoo, G. W., Chia, D., Kim, Y., Li, F., Elashoff, D., Grognan, T., Tu, M., Liao, W., Xian, R., Grody, W. W., Su, W. C. & Wong, D. T. W., 2018 Nov, In : Journal of Molecular Diagnostics. 20, 6, p. 738-742 5 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
4 Citations (Scopus)
2017

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

Wang, S. A., Wang, Y. C., Chuang, Y. P., Huang, Y. H., Su, W. C., Chang, W. C. & Hung, J. J., 2017 May 25, In : Oncogene. 36, 21, p. 2930-2945 16 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2019

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Yang, J. C. H., Gadgeel, S. M., Sequist, L. V. D., Wu, C. L., Papadimitrakopoulou, V. A., Su, W. C., Fiore, J., Saraf, S., Raftopoulos, H. & Patnaik, A., 2019 Mar, In : Journal of Thoracic Oncology. 14, 3, p. 553-559 7 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
2018

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 Nov 1, In : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

Research output: Contribution to journalArticle

50 Citations (Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 Dec, In : Lung Cancer. 126, p. 133-138 6 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy

Yen, C. C., Su, H. C., Chu, C. Y., Lai, S. J., Yan, J. J., Su, W. P. & Su, W. C., 2018 Jun, In : Lung Cancer. 120, p. 149-151 3 p.

Research output: Contribution to journalLetter

2020
2016
78 Citations (Scopus)
2020

Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model

Chien, L. H., Chen, C. H., Chen, T. Y., Chang, G. C., Tsai, Y. H., Hsiao, C. F., Chen, K. Y., Su, W. C., Wang, W. C., Huang, M. S., Chen, Y. M., Chen, C. Y., Liang, S. K., Chen, C. Y., Wang, C. L., Lee, M. H., Chung, R. H., Tsai, F. Y., Hu, J. W., Katki, H. A. & 8 others, Chatterjee, N., Chanock, S. J., Rothman, N., Lan, Q., Yang, P. C., Chen, C. J., Chang, I. S. & Hsiung, C. A., 2020 Feb 1, In : Cancer Epidemiology Biomarkers and Prevention. 29, 2, p. 452-459 8 p.

Research output: Contribution to journalArticle

Open Access

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

Chen, Y. M., Chih-Hsin Yang, J., Su, W. C., Chong, I. W., Hsia, T. C., Lin, M. C., Chang, G. C., Chiu, C. H., Ho, C. C., Wu, S. Y., Hung, J. Y., Wang, C. C., Yang, T. Y. & Yu, C. J., 2020, (Accepted/In press) In : Journal of the Formosan Medical Association.

Research output: Contribution to journalArticle

Open Access
2016
7 Citations (Scopus)
2018
Open Access
1 Citation (Scopus)
2019
Open Access
2016

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

Jen, J., Lin, L. L., Chen, H. T., Liao, S. Y., Lo, F. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2016 May 5, In : Oncogene. 35, 18, p. 2357-2369 13 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)